Remove digital how-do-we-unlock-potential-digital-health
article thumbnail

How do we unlock the potential of digital health?

pharmaphorum

Unlock the power of digital health through AI and clinical advancements. Learn how these technologies are shaping the future of healthcare and how to harness their potential.

118
118
article thumbnail

DTx for women’s mental health – Woebot and postpartum depression

pharmaphorum

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

In-Vivo 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Deep Dive: Communications & Commercialisation 2022

pharmaphorum

Cut off from tried and tested methods of engaging with stakeholders, digital, and virtual solutions were thrust into the limelight as the industry proactively accelerated the adoption of technology across all levels of healthcare. We chart the unusual metamorphosis of pharma marketing, from patent pages to personalised apps.

article thumbnail

Recent advances in neurological disorders

pharmaphorum

In everything we do, our guiding question is: What difference will this make for patients?” The next consideration typically is how do we help ensure those patients who benefit from treatment can access it. We are committed to continuing our efforts to lead in this space.”.

article thumbnail

What can Rishi Sunak do for the UK’s pharma industry

Pharmaceutical Technology

billion) per year by the end of the Parliament in additional funding for the National Health Service (NHS), thus raising the agency’s funding by over 29%. These are significant to the business and [it] will be catastrophic if we lost them.” UK’s competitive potential. This would come from “£16.3 says O’Meara.

article thumbnail

Sitting down with… Stefanie Dedeurwaerdere, UCB

Drug Discovery World

We now commonly refer to epilepsy as ‘epilepsies’, with the recognition that it isn’t a singular disease. SD : At UCB, we currently have several drug discovery projects running, which we are very excited about. LR: Can you share the latest epilepsy research trends? SD : There are multiple types of epilepsy.

article thumbnail

Mastering 21 CFR Part 11 Compliance: A Comprehensive Guide for Clinical Trials in the Digital Age

Cloudbyz

These rules serve as a regulatory benchmark, allowing digital transactions to be as trustworthy and reliable as paper ones. How to Ensure Compliance Here are some steps to ensure your clinical trial complies with 21 CFR Part 11: 1. Food and Drug Administration (FDA). Its central focus is electronic records and signatures.